Bvf Inc Axsome Therapeutics, Inc. Transaction History
Bvf Inc
- $3.15 Billion
- Q3 2024
A detailed history of Bvf Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,046,000 shares of AXSM stock, worth $102 Million. This represents 2.99% of its overall portfolio holdings.
Number of Shares
1,046,000
Previous 955,000
9.53%
Holding current value
$102 Million
Previous $76.9 Million
22.25%
% of portfolio
2.99%
Previous 2.35%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
324Shares Held
37.7MCall Options Held
797KPut Options Held
747K-
Rtw Investments, LP New York, NY4.19MShares$410 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$323 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$231 Million34.46% of portfolio
-
Ra Capital Management, L.P. Boston, MA1MShares$97.8 Million1.25% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.19B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...